AnaptysBio Debt to Equity Ratio 2014-2018 | ANAB

Current and historical debt to equity ratio values for AnaptysBio (ANAB) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. AnaptysBio debt/equity for the three months ending June 30, 2018 was 0.01.
AnaptysBio Annual Debt/Equity Ratio
2017 0.05
2016 0.35
2015 0.12
2014 0.80
2013 5.64
AnaptysBio Quarterly Debt/Equity Ratio
Q2 2018 0.04
Q1 2018 0.05
Q4 2017 0.05
Q3 2017 0.14
Q2 2017 0.13
Q1 2017 0.13
Q4 2016 0.35
Q3 2016 0.00
Q2 2016 0.00
Q1 2016 0.00
Q4 2015 0.00
Q4 2014 0.00
Q4 2013 0.00
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $2.168B $0.010B
AnaptysBio, Inc. is a biotechnology company. It involved in the discovery and development of therapeutic antibodies for inflammation and immuno-oncology primarily in the Unites states. AnaptysBio, Inc. is based in San Diego, California.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $131.526B 15.10
Gilead Sciences (GILD) United States $95.774B 10.63
Biogen (BIIB) United States $68.271B 14.47
Celgene (CELG) United States $61.460B 12.27
Illumina (ILMN) United States $51.504B 64.53
Vertex Pharmaceuticals (VRTX) United States $45.132B 102.67
Regeneron Pharmaceuticals (REGN) United States $41.461B 23.31
Alexion Pharmaceuticals (ALXN) United States $27.182B 20.43
BioMarin Pharmaceutical (BMRN) United States $17.718B 0.00
Incyte (INCY) United States $14.296B 480.36
Seattle Genetics (SGEN) United States $12.306B 0.00
Sarepta Therapeutics (SRPT) United States $10.096B 0.00
Alnylam Pharmaceuticals (ALNY) United States $9.545B 0.00
Exact Sciences (EXAS) United States $9.101B 0.00
Bio-Rad Laboratories (BIO.B) United States $8.881B 57.03
BeiGene (BGNE) Cayman Islands $8.791B 0.00
QIAGEN (QGEN) Netherlands $8.705B 28.46
Bluebird Bio (BLUE) United States $7.653B 0.00
Bio-Techne Corp (TECH) United States $7.499B 50.15
Alkermes (ALKS) Ireland $6.147B 0.00
Galapagos (GLPG) Belgium $5.897B 0.00
Ligand Pharmaceuticals (LGND) United States $5.575B 49.38
Exelixis (EXEL) United States $4.900B 15.96
Ultragenyx Pharmaceutical (RARE) United States $4.310B 0.00
Immunomedics (IMMU) United States $4.123B 0.00
Intercept Pharmaceuticals (ICPT) United States $3.529B 0.00
MorphoSys AG Unsponsored ADR (MOR) Germany $3.447B 0.00
Myriad Genetics (MYGN) United States $3.394B 37.98
Emergent Biosolutions (EBS) United States $3.316B 26.41
Array BioPharma (ARRY) United States $3.145B 0.00
Blueprint Medicines (BPMC) United States $3.143B 0.00
Horizon Pharma Public (HZNP) Ireland $3.141B 17.78
Ascendis Pharma (ASND) Denmark $2.824B 0.00
China Biologic Products (CBPO) China $2.708B 17.88
Acceleron Pharma (XLRN) United States $2.592B 0.00
ARGENX SE-ADR (ARGX) Netherlands $2.573B 0.00
Reata Pharmaceuticals (RETA) United States $2.538B 0.00
Repligen (RGEN) United States $2.527B 84.82
Medicines (MDCO) United States $2.479B 0.00
MyoKardia (MYOK) United States $2.473B 0.00
CRISPR THERAPTC (CRSP) Switzerland $2.469B 0.00
Genomic Health (GHDX) United States $2.465B 137.50
Halozyme Therapeutics (HALO) United States $2.460B 32.79
Akcea Therapeutics (AKCA) United States $2.319B 0.00
REGENXBIO (RGNX) United States $2.250B 35.35
Amicus Therapeutics (FOLD) United States $2.234B 0.00
Momenta Pharmaceuticals (MNTA) United States $2.130B 0.00
Spark Therapeutics (ONCE) United States $2.128B 0.00
Global Blood Therapeutics (GBT) United States $2.126B 0.00
Cambrex (CBM) United States $2.092B 16.77
Arena Pharmaceuticals (ARNA) United States $2.075B 0.00
G1 THERAPEUTICS (GTHX) United States $2.004B 0.00
Denali Therapeutics (DNLI) United States $1.936B 0.00
Allakos (ALLK) United States $1.907B 0.00
ACADIA Pharmaceuticals (ACAD) United States $1.888B 0.00
Mirati Therapeutics (MRTX) United States $1.854B 0.00
Puma Biotechnology (PBYI) United States $1.818B 0.00
Atara Biotherapeutics (ATRA) United States $1.814B 0.00
Solid Biosciences (SLDB) United States $1.738B 0.00
Myovant Sciences (MYOV) United Kingdom $1.725B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $1.709B 0.00
Clovis Oncology (CLVS) United States $1.696B 0.00
Rubius Therapeutics (RUBY) United States $1.618B 0.00
Aimmune Therapeutics (AIMT) United States $1.611B 0.00
Editas Medicine (EDIT) United States $1.582B 0.00
Insmed (INSM) United States $1.565B 0.00
Sangamo Therapeutics (SGMO) United States $1.561B 0.00
Innoviva (INVA) United States $1.545B 9.91
Biohaven Pharmaceutical Holding (BHVN) United States $1.495B 0.00
Audentes Therapeutics (BOLD) United States $1.470B 0.00
Kiniksa Pharmaceuticals (KNSA) Bermuda $1.450B 0.00
WAVE Life Sciences (WVE) Singapore $1.441B 0.00
UniQure (QURE) Netherlands $1.432B 0.00
Intellia Therapeutics (NTLA) United States $1.382B 0.00
IMMURON LTD (IMRN) Australia $1.371B 0.00
DBV Technologies (DBVT) France $1.371B 0.00
Deciphera Pharmaceuticals (DCPH) United States $1.370B 0.00
Lion Biotechnologies (IOVA) United States $1.305B 0.00
Retrophin (RTRX) United States $1.194B 0.00
NeoGenomics (NEO) United States $1.192B 208.57
Viking Therapeutics (VKTX) United States $1.192B 0.00
Cellectis (CLLS) France $1.190B 0.00
Intra-Cellular Therapies (ITCI) United States $1.160B 0.00
Autolus Therapeutics Sponsored ADR (AUTL) United Kingdom $1.142B 0.00
Lexicon Pharmaceuticals (LXRX) United States $1.138B 0.00
Coherus BioSciences (CHRS) United States $1.119B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $1.117B 0.00
Zai Lab Unsponsored ADR (ZLAB) China $1.114B 0.00
Alder BioPharmaceuticals (ALDR) United States $1.088B 0.00
Athenex (ATNX) United States $1.079B 0.00
AVROBIO (AVRO) United States $1.077B 0.00
Rhythm Pharmaceuticals (RYTM) United States $1.068B 0.00
Vanda Pharmaceuticals (VNDA) United States $1.029B 1965.00
Apellis Pharmaceuticals (APLS) United States $1.014B 0.00
Geron (GERN) United States $1.012B 0.00
Dicerna Pharmaceuticals (DRNA) United States $1.009B 0.00
Aptinyx (APTX) United States $0.928B 0.00
Inotek Pharmaceuticals (RCKT) United States $0.906B 0.00
Revance Therapeutics (RVNC) United States $0.887B 0.00
Cara Therapeutics (CARA) United States $0.872B 0.00
Acorda Therapeutics (ACOR) United States $0.855B 17.82
CytomX Therapeutics (CTMX) United States $0.841B 0.00
Amarin (AMRN) Ireland $0.833B 0.00
Heska (HSKA) United States $0.825B 71.02
InflaRx (IFRX) Germany $0.796B 0.00
ProQR Therapeutics (PRQR) Netherlands $0.759B 0.00
Dynavax Technologies (DVAX) United States $0.748B 0.00
NuCana Sponsored ADR (NCNA) United Kingdom $0.743B 0.00
Nightstar Therapeutics Sponsored ADR (NITE) United States $0.726B 0.00
UNITY Biotechnology (UBX) $0.721B 0.00
Epizyme (EPZM) United States $0.719B 0.00
Fate Therapeutics (FATE) United States $0.714B 0.00
AMAG Pharmaceuticals (AMAG) United States $0.714B 0.00
Abeona Therapeutics (ABEO) United States $0.662B 0.00
UROGEN PHARMA (URGN) Israel $0.654B 0.00
Verastem (VSTM) United States $0.650B 0.00
Scholar Rock Holding (SRRK) United States $0.638B 0.00
ObsEva SA (OBSV) Switzerland $0.637B 0.00
Kura Oncology (KURA) United States $0.636B 0.00
ANI Pharmaceuticals (ANIP) United States $0.631B 12.49
Arcus Biosciences (RCUS) United States $0.623B 0.00
MiMedx (MDXG) United States $0.611B 26.19
Mesoblast (MESO) Australia $0.605B 0.00
Vericel (VCEL) United States $0.600B 0.00
Anika Therapeutics (ANIK) United States $0.591B 24.85
Replimune (REPL) United States $0.575B 0.00
BeyondSpring (BYSI) United States $0.568B 0.00
Zealand Pharma (ZEAL) Denmark $0.562B 0.00
Novavax (NVAX) United States $0.547B 0.00
AC Immune SA (ACIU) Switzerland $0.547B 0.00
Stemline Therapeutics (STML) United States $0.541B 0.00
Prothena (PRTA) Ireland $0.532B 0.00
Sorrento Therapeutics (SRNE) United States $0.531B 91.00
GTx (GTXI) United States $0.527B 0.00
Arbutus Biopharma (ABUS) Canada $0.518B 0.00
Senesco Technologies (ELOX) United States $0.516B 0.00
Five Prime Therapeutics (FPRX) United States $0.507B 0.00
Aduro Biotech (ADRO) United States $0.506B 0.00
Zymeworks (ZYME) Canada $0.490B 0.00
RA PHARMCTL INC (RARX) United States $0.467B 0.00
MediciNova (MNOV) United States $0.463B 0.00
Cytokineticsorporated (CYTK) United States $0.456B 0.00
Achillion Pharmaceuticals (ACHN) United States $0.452B 0.00
Merus (MRUS) Netherlands $0.446B 0.00
Inovio Pharmaceuticals (INO) United States $0.441B 0.00
Kindred Biosciences (KIN) United States $0.438B 0.00
Evelo Biosciences (EVLO) United States $0.430B 0.00
Sinovac Biotech (SVA) China $0.426B 0.00
ZIOPHARM Oncology Inc (ZIOP) United States $0.426B 0.00
Eidos Therapeutics (EIDX) United States $0.420B 0.00
Syros Pharmaceuticals (SYRS) United States $0.415B 0.00
Albireo Pharma (ALBO) United States $0.400B 0.00
Osiris Therapeutics (OSIR) United States $0.397B 0.00
ResTORbio (TORC) United States $0.394B 0.00
Magenta Therapeutics (MGTA) United States $0.382B 0.00
Kadmon Holdings (KDMN) United States $0.378B 0.00
Kezar Life Sciences (KZR) United States $0.370B 0.00
Unum Therapeutics (UMRX) United States $0.367B 0.00
Adverum Biotechnologies (ADVM) United States $0.367B 0.00
Peregrine Pharmaceuticals (CDMO) United States $0.361B 0.00
Keryx Biopharmaceuticals (KERX) United States $0.357B 0.00
Cellular Biomedicine (CBMG) United States $0.347B 0.00
Clementia Pharmaceuticals (CMTA) Canada $0.346B 0.00
PDL BioPharma (PDLI) United States $0.345B 4.84
AVEO Pharmaceuticals (AVEO) United States $0.342B 0.00
Synlogic (SYBX) United States $0.341B 0.00
Sienna Biopharmaceuticals (SNNA) United States $0.328B 0.00
Selecta Biosciences (SELB) United States $0.321B 0.00
MeiraGTx Holdings (MGTX) United States $0.320B 0.00
Seres Therapeutics (MCRB) United States $0.307B 0.00
Celcuity (CELC) United States $0.302B 0.00
Biofrontera AG Sponsored ADR (BFRA) Germany $0.302B 0.00
ADMA Biologics Inc (ADMA) United States $0.301B 0.00
BioTime (BTX) United States $0.294B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.292B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.290B 0.00
Liquidia Technologies (LQDA) United States $0.285B 0.00
Mersana Therapeutics (MRSN) United States $0.280B 0.00
Corvus Pharmaceuticals (CRVS) United States $0.276B 0.00
Celyad SA (CYAD) Belgium $0.272B 0.00
Kala Pharmaceuticals (KALA) United States $0.263B 0.00
MannKind (MNKD) United States $0.263B 0.00
Athersys (ATHX) United States $0.259B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.257B 0.00
Axovant Sciences (AXON) United Kingdom $0.255B 0.00
Menlo Therapeutics (MNLO) United States $0.253B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.250B 0.00
NantKwest (NK) United States $0.245B 0.00
TOCAGEN INC (TOCA) United States $0.243B 0.00
Kamada (KMDA) Israel $0.242B 18.75
Allena Pharmaceuticals (ALNA) United States $0.230B 0.00
Agenus (AGEN) United States $0.227B 0.00
Idera Pharmaceuticals (IDRA) United States $0.225B 0.00
Palatin Technologies (PTN) United States $0.208B 8.58
Enzo Biochem (ENZ) United States $0.207B 0.00
Clearside Biomedical (CLSD) United States $0.206B 0.00
ChromaDex (CDXC) United States $0.201B 0.00
Protagonist Therapeutics (PTGX) United States $0.199B 0.00
Strongbridge Biopharma (SBBP) United States $0.199B 0.00
Compugen (CGEN) Israel $0.195B 0.00
Spero Therapeutics (SPRO) United States $0.188B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.187B 0.00
Cue Biopharma (CUE) United States $0.186B 0.00
Erytech Pharma SA Sponsored ADR (ERYP) $0.184B 0.00
Constellation Pharmaceuticals (CNST) United States $0.180B 0.00
Signal Genetics (MGEN) United States $0.177B 0.00
Cohbar (CWBR) United States $0.175B 0.00
Mustang Bio (MBIO) United States $0.174B 0.00
Monster Digital (INNT) United States $0.174B 0.00
Krystal Biotech (KRYS) United States $0.171B 0.00
Eiger BioPharmaceuticals (EIGR) United States $0.171B 0.00
Verona Pharma American Depositary Share (VRNA) United Kingdom $0.163B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.162B 0.00
Eleven Biotherapeutics (SESN) United States $0.162B 0.00
BioDelivery Sciences (BDSI) United States $0.161B 0.00
Pfenex (PFNX) United States $0.158B 0.00
Spring Bank Pharmaceuticals (SBPH) United States $0.158B 0.00
Cerecor (CERC) United States $0.156B 18.67
Nymox Pharmaceutical (NYMX) Canada $0.153B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.151B 0.00
Pluristem Therapeutics (PSTI) Israel $0.150B 0.00
OVID THERAPEUTC (OVID) United States $0.144B 0.00
Provention Bio (PRVB) United States $0.144B 0.00
Intec Pharma (NTEC) Israel $0.143B 0.00
Checkpoint Therapeutics (CKPT) United States $0.141B 0.00
PSivida (EYPT) United States $0.135B 0.00
XOMA (XOMA) United States $0.135B 14.22
Organovo Holdings (ONVO) United States $0.132B 0.00
Tapimmune (TPIV) United States $0.127B 0.00
Motif Bio Plc (MTFB) United States $0.126B 0.00
Trevena (TRVN) United States $0.124B 0.00
BioXcel Therapeutics (BTAI) United States $0.119B 0.00
VBI Vaccines (VBIV) United States $0.118B 0.00
Aptevo Therapeutics (APVO) United States $0.115B 0.00
Cidara Therapeutics (CDTX) United States $0.115B 0.00
Catalyst Biosciences (CBIO) United States $0.115B 0.00
Anavex Life Sciences (AVXL) United States $0.113B 0.00
OncoMed Pharmaceuticals (OMED) United States $0.108B 0.00
Cel-Sci (CVM) United States $0.103B 0.00
Leap Therapeutics (LPTX) United States $0.102B 0.00
ARIDIS PHARMACT (ARDS) United States $0.101B 0.00
Alcobra (ARCT) United States $0.101B 0.00
Vaccinex (VCNX) United States $0.100B 0.00
XBiotech (XBIT) United States $0.099B 0.00
Neothetics (EVFM) United States $0.098B 0.00
ScPharmaceuticals (SCPH) United States $0.096B 0.00
Aptose Biosciences (APTO) Canada $0.093B 0.00
Protalix BioTherapeutics (PLX) Israel $0.091B 0.00
Fortress Biotech (FBIO) United States $0.090B 0.00
Proteostasis Therapeutics (PTI) United States $0.090B 0.00
Ophthotech (OPHT) United States $0.087B 0.57
NewLink Genetics (NLNK) United States $0.087B 0.00
Prima BioMed (IMMP) Australia $0.084B 0.00
Axsome Therapeutics (AXSM) United States $0.083B 0.00
Brainstorm Cell Therapeutics (BCLI) United States $0.082B 0.00
Sophiris Bio (SPHS) United States $0.081B 0.00
VolitionRX (VNRX) Singapore $0.080B 0.00
Evogene (EVGN) Israel $0.080B 0.00
Applied Genetic Technologies (AGTC) United States $0.079B 0.00
Orgenesis (ORGS) United States $0.078B 0.00
Asterias Biotherapeutics (AST) United States $0.078B 0.00
Cocrystal Pharma (COCP) United States $0.076B 0.00
Merrimack Pharmaceuticals (MACK) United States $0.076B 0.00
Alimera Sciences (ALIM) United States $0.075B 0.00
Chiasma (CHMA) United States $0.074B 0.00
Novelion Therapeutics (NVLN) Canada $0.074B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.071B 0.00
Oncolytics Biotech (ONCY) Canada $0.070B 0.00
OncoSec Medical (ONCS) United States $0.070B 0.00
Celldex Therapeutics (CLDX) United States $0.068B 0.00
TRACON Pharmaceuticals (TCON) United States $0.066B 0.00
Oncobiologics (ONS) United States $0.065B 0.00
Bellerophon Therapeutics (BLPH) United States $0.065B 0.00
Caladrius Biosciences (CLBS) United States $0.059B 0.00
CorMedix Inc (CRMD) United States $0.059B 0.00
Entera Bio (ENTX) Israel $0.059B 0.00
Rexahn Pharmaceuticals (RNN) United States $0.058B 0.00
Catabasis Pharmaceuticals (CATB) United States $0.058B 0.00
Curis (CRIS) United States $0.055B 0.00
VIVUS (VVUS) United States $0.053B 0.00
Aileron Therapeutics (ALRN) United States $0.050B 0.00
Celsion (CLSN) United States $0.050B 0.00
Vascular Biogenics (VBLT) Israel $0.049B 0.00
Zosano Pharma (ZSAN) United States $0.047B 0.00
Eyenovia (EYEN) United States $0.046B 0.00
Moleculin Biotech (MBRX) United States $0.044B 0.00
Advaxis (ADXS) United States $0.044B 0.00
AZURRX BIOPHARM (AZRX) United States $0.043B 0.00
BioPharmX (BPMX) United States $0.041B 0.00
Proteon Therapeutics (PRTO) United States $0.038B 0.00
BiondVax Pharmaceuticals (BVXV) Israel $0.038B 0.00
GENPREX INC (GNPX) United States $0.037B 0.00
CytRx (CYTR) United States $0.035B 0.00
VistaGen Therapeutics (VTGN) United States $0.035B 0.00
AquaBounty Technologies (AQB) United States $0.034B 0.00
Gemphire Therapeutics (GEMP) United States $0.033B 0.00
Vical (VICL) United States $0.030B 0.00
VTv Therapeutics (VTVT) United States $0.029B 0.00
Soligenix (SNGX) United States $0.027B 0.00
AEterna Zentaris (AEZS) United States $0.027B 54.39
Cellect Biotechnology (APOP) Israel $0.026B 0.00
Benitec Biopharma (BNTC) Australia $0.026B 0.00
OvaScience (OVAS) United States $0.025B 0.00
Arsanis (ASNS) United States $0.025B 0.00
ATyr Pharma (LIFE) United States $0.025B 0.00
Akari Therapeutics (AKTX) United Kingdom $0.024B 0.00
Edge Therapeutics (EDGE) United States $0.022B 0.00
RestorGenex (DFFN) United States $0.022B 0.00
Galena Biopharma (SLS) United States $0.022B 0.00
Cleveland BioLabs (CBLI) United States $0.021B 0.00
Fibrocell Science Inc (FCSC) United States $0.020B 0.00
Adial Pharmaceuticals (ADIL) United States $0.019B 0.00
Pulmatrix (PULM) United States $0.018B 0.00
Prana Biotechnology (PRAN) Australia $0.018B 0.00
Genetic Technologies (GENE) Australia $0.018B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.017B 0.00
Histogenics (HSGX) United States $0.016B 0.00
Neuralstem (CUR) United States $0.016B 0.00
Novogen (KZIA) Australia $0.016B 0.00
AmpliPhi Biosciences (APHB) United States $0.014B 0.00
TrovaGene (TROV) United States $0.014B 0.00
Therapix Biosciences (TRPX) Israel $0.014B 5.26
Vital Therapies (VTL) United States $0.014B 0.00
Titan Pharmaceuticals (TTNP) United States $0.012B 0.00
Alliqua BioMedical (ALQA) United States $0.012B 0.00
Cerulean Pharma (DARE) United States $0.011B 0.00
Hemispherx BioPharma (HEB) United States $0.011B 0.00
IBio (IBIO) United States $0.010B 0.00
ContraVir Pharmaceuticals Inc (CTRV) United States $0.009B 0.00
ImmunoCellular Therapeutics (IMUC) United States $0.009B 0.00
MYOS RENS Technology (MYOS) United States $0.008B 0.00
Flex Pharma (FLKS) United States $0.008B 0.00
Synthetic Biologics (SYN) United States $0.008B 0.00
Stellar Biotechnologies (SBOT) United States $0.007B 0.00
Tenax Therapeutics (TENX) United States $0.007B 0.00
ARCA Biopharma (ABIO) United States $0.007B 0.00
Oragenics (OGEN) United States $0.006B 0.00
Aytu Bioscience (AYTU) United States $0.005B 0.00
Cytori Therapeutics Inc (CYTX) United States $0.003B 0.00